Search results (221)
« Back to NewsWellcome Career Development Award For Agne Antanaviciute
2 April 2025
Dr Agne Antanaviciute has won a Wellcome Career Development Award for her research investigating early-life immunity.
Landmark study finds no benefit of routine use of cerebral embolic protection devices on TAVI stroke risk
31 March 2025
Researchers say the devices cannot be recommended for routine clinical use in the UK.
New study reveals details of key immune mechanism
25 March 2025
An international collaboration, initiated by the Jackson Group at the MRC Weatherall Institute of Molecular Medicine, has uncovered new information that could help in the development of drugs to block conditions such as autoimmunity and inflammation.
Ancient genomic linkage regulates red blood cell development
24 March 2025
A collaboration between the Drakesmith and Higgs Groups at the MRC Weatherall Institute of Molecular Medicine has identified an ancient connection between metabolic and transcriptional control of erythropoiesis.
Wellcome Career Development Award For Sumana Sharma
14 March 2025
Dr Sumana Sharma has won a Wellcome Career Development Award for her research investigating receptors in T cells.
New research findings help identify those most at risk of developing hypertrophic cardiomyopathy
27 February 2025
Two new research papers, published in Nature Genetics, jointly led by RDM’s Professor Hugh Watkins, have further advanced our understanding of the genetic basis of hypertrophic cardiomyopathy (HCM).
Clinical trials begin for a first-in-class, inhaled gene therapy for people with cystic fibrosis
25 February 2025
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
RDM researchers collaborate on postpartum blood pressure self-monitoring trial in the US
18 December 2024
Researchers in RDM’s Cardiovascular Clinical Research Facility (CCRF) will collaborate with the University of Pennsylvania on a new trial to understand the potential benefits of postpartum blood pressure monitoring in the US healthcare system.
Researchers provide a perspective on mapping the bone marrow using new spatial transcriptomic technologies
13 December 2024
RDM researchers have outlined the potential benefits and limitations of new spatial transcriptomic technologies for mapping the bone marrow in patients with blood cancer.
Support for RDM research in diagnosing and managing heart failure
13 December 2024
The Kusuma Trust has made an award of £400K to fund research in diagnosing and managing heart failure.
New MRC Centre to create cutting-edge gene therapies
11 December 2024
Professor Deborah Gill is to co-lead an MRC research centre being launched to develop new advanced treatments for currently untreatable diseases.
Renewal of the Novo Nordisk – University of Oxford Fellowship Programme
2 December 2024
Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.
Davis Group receives Wellcome Discovery Award
2 December 2024
Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled “Small contacts, big decisions – early signal processing by T cells”. This has been awarded jointly with Professor Anna Lippert of the University of Würzburg.
Transformative treatments for children with fatal genetic lung diseases
15 November 2024
AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.
Launch of the new BHF Oxford Centre of Research Excellence
14 November 2024
Celebrating a £5million British Heart Foundation renewal award to the University of Oxford to advance cardiovascular science.
Under-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population
24 October 2024
People diagnosed with type 2 diabetes before 40 years of age, have nearly four times the risk of death compared with the general UK population, a new study carried out at the University of Oxford’s Radcliffe Department of Medicine has found.
New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs
22 October 2024
Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.
Researchers develop new tool to better predict acute myeloid leukaemia outcomes in older patients
17 September 2024
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.